Barely Significant
← all excerpts

UICC Staging after Neoadjuvant/Perioperative Chemotherapy Reveals No Significant Survival Differences Compared to Primary Surgery for Locally Advanced Gastric Cancer.

Cancers (Basel) · 2022 · PMC9777228 · PMID 36551654

Europe PMCDOI
1
hedged sentence
0.4400
closest p · 8.8× alpha
0.4400
boldest claim

The sentences

a weakly significant differencep = 0.44not close (p > 0.1)
not reached; HR 0.26; CI 95% 0.06–1.08; p = 0.05) revealed a weakly significant difference in survival, and stages pT2–pT4 revealed no significant difference in survival (pT2 vs. ypT2: median OS 129 months vs. not reached; HR 0.78; CI 95% 0.42–1.46; p = 0.44; pT3 vs. ypT3: median OS 58 vs. 91 months; HR 0.83; CI 95% 0.61–1.13; p = 0.24, pT4 vs. ypT4: median OS 30 vs. 31 months; HR 0.84; CI 95% 0.58–1.21; p = 0.35).

also in 56 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.